Sengupta Utpal
Molecular Biology and Immunology, Stanley Browne Laboratory, TLM Community Hospital, New Delhi, India.
Indian J Dermatol Venereol Leprol. 2018;84(2):131-136. doi: 10.4103/ijdvl.IJDVL_1070_16.
India attained the elimination figure of less than 1 case of leprosy per 10,000 people during December 2005. Despite this, India still accounts for the largest number of new leprosy cases in the world, maintaining more than 50 per cent of the leprosy burden of the world, notwithstanding over three decades of use of multidrug therapy. The present review analyzes the process of execution of the elimination program, identifies any lacunae therein and presents corrective measures that could be taken up for elimination of the disease from the country.
2005年12月，印度实现了麻风病患病率降至每万人不到1例的目标。尽管如此，印度仍是世界上新发麻风病病例数最多的国家，尽管已使用多药疗法三十多年，但该国仍承担着全球超过50%的麻风病负担。本综述分析了消除麻风病项目的实施过程，找出其中存在的漏洞，并提出可采取的纠正措施，以便在该国消除这种疾病。
